Found: 9
Select item for more details and to access through your institution.
Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 159, doi. 10.1007/s10637-018-0650-5
- By:
- Publication type:
- Article
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 700, doi. 10.1007/s10637-014-0089-2
- By:
- Publication type:
- Article
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 330, doi. 10.1007/s10637-013-0042-9
- By:
- Publication type:
- Article
Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 954, doi. 10.1634/theoncologist.2020-0474
- By:
- Publication type:
- Article
Construction and biomedical application of immunosensors based on fiber optics and enhanced chemiluminescence.
- Published in:
- Optical Engineering, 1994, v. 33, n. 9, p. 2958
- By:
- Publication type:
- Article
Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 2, p. 251, doi. 10.1007/s00280-012-1911-1
- By:
- Publication type:
- Article
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 95, doi. 10.1007/s00280-012-1889-8
- By:
- Publication type:
- Article
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 2, p. 664, doi. 10.1111/cts.12928
- By:
- Publication type:
- Article